Composition for use in the treatment of diseases associated with dysfunction of mitochondriae
OwnerJean KRUTMANN, Marc MAJORAinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerJean KRUTMANN, Marc MAJORAinventors
Estimating the term…
The present invention relates to compositions comprising a methyl group donor compound and an acetyl-CoA donor compound for use in therapy and prevention of diseases associated with dysfunction of mitochondriae, wherein the diseases associated with dysfunction of mitochondriae are nucleotide excision repair deficiency syndromes, especially Xeroderma pigmentosum A, or DNA repair deficiency syndrome ataxia telangiectasia associated with mitochondrial dysfunction. Particularly, the composition is used for therapy of nucleotide excision repair deficiency syndromes, such as Xeroderma pigmentosum A, B, C, D, E, F, G, V, the different forms of Cockayne syndrome (CS), such as Cockayne syndrome type B (CSB) and Cockayne syndrome type A (CSA), and trichothiodystrophy (TTD), or DNA repair deficiency syndrome ataxia telangiectasia associated with mitochondrial dysfunction.
A method for the treatment of a disease associated with dysfunction of mitochondriae, comprising administering i) a first compound A, which is a methyl group donor, and
A pharmaceutical composition comprising:
Dependencies are inferred from the claim text.